We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Researchers from Mater Research have been awarded more than $1.84 million in National Health and Medical Research Council (NHMRC) funding.
Mater Group is proud to mark a milestone in its history, the launch of a new brand, to reposition Mater as a group incorporating health, education and research for a ...
A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.
A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.
A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).
Mater Research is planning the largest group cohort study in the state since the 1980s, aiming to follow 10 000 Queensland families over three decades, in ...
Dr Peter Steer announced as new Mater Group Chief Executive Officer
Chairman of the Board at Mater Group, Mr Brian Flannery announced this week that Dr Peter Steer ...
Mater researcher Professor Geoff Faulkner and his lab have published a paper that explores the development of resistance to chemotherapy in ovarian cancer. Each year ...
Prof Peter Nestor was recently appointed Conjoint Professor of Neuroscience between The University of Queensland and Mater and has started his appointment by ...
Two female researchers in Queensland have been awarded strategic grants as a step forward in closing the research and academic gender gap.
The world’s leading minds on ocular melanoma say more must be done to help the 50 per cent of patients who die from melanoma of the eye in Australia.
A Queensland trial will evaluate the benefits of medicinal cannabis for symptom relief in cancer patients receiving palliative care.
At Mater, we value effective communication—with staff, patients and the community. To keep up to date with news at Mater, you can review the latest news updates on this page or you can follow us or join the conversation on our social media pages.
A Media and Communications Officer is on-call 24 hours a day, seven days a week. To contact the on-call officer, please call Mater Switch on 07 3163 8111 and ask to be put through to the Media and Communications Officer on-call or give us online feedback